Manchester is a founding partner in the International Alliance for Cancer Early Detection (ACED). But what is ACED, and what early detection research are Manchetser researchers pioneering? We spoke with Martin Bone, ACED Programme Manager, to find out.

This Women and Girls in Science Day there was one person whose name rang out as the perfect fit for an interview. Dr Rachel Eyre is a breast cancer research scientist in the Oglesby Building. She researches breast cancer metastasis, particularly focussing on the role of cancer stem cells and IL1β in driving this process. She is also a mum of three, including twins.

This year the NCRI’s annual cancer conference was in Glasgow for the first time. The MCRC team took a trip north of the border to catch up with the rest of the UK’s cancer research community. Here are some of our highlights.

Will Bleaney is a clinical fellow who has just entered the second year of his PhD project, supervised by Prof Andrew Sharrocks, Prof Yeng Ang and Dr Was Mansoor.

Megan Thompson is a PhD student who has just entered the second year of her four-year project.

Niluja Thiru is a clinical fellow who has just entered the second year of her PhD project, supervised by Professors Catharine West, Ananya Choudhury and Robert Bristow.

My MCRC focuses on the individuals that work for the MCRC. Each post can take whatever shape the writer wants. This month Postdoctorial Scientist Richard Rebello reflects on his past 6 months at the MCRC. 

Mike Thorpe attended the #MCRCancerTeamScience Prostate Town Hall as a patient advocate. This was his experiance. 

‘We have been conducting our team-science town halls at MCRC as many of you will have attended. Our team science workshop, jointly run with HeRC on 31st July, feeds directly into this work.

This week we welcome guest blogger Nina Hayes-Thompson, HeRC Communications Officer, to tell you more.”

David Jenkins is, in his own words, “an unusual purchasing officer". We wanted to find out a little more about him.